Correlation Between Supernus Pharmaceuticals and Creative Edge

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Supernus Pharmaceuticals and Creative Edge at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Supernus Pharmaceuticals and Creative Edge into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Supernus Pharmaceuticals and Creative Edge Nutrit, you can compare the effects of market volatilities on Supernus Pharmaceuticals and Creative Edge and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Supernus Pharmaceuticals with a short position of Creative Edge. Check out your portfolio center. Please also check ongoing floating volatility patterns of Supernus Pharmaceuticals and Creative Edge.

Diversification Opportunities for Supernus Pharmaceuticals and Creative Edge

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Supernus and Creative is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Supernus Pharmaceuticals and Creative Edge Nutrit in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Creative Edge Nutrit and Supernus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Supernus Pharmaceuticals are associated (or correlated) with Creative Edge. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Creative Edge Nutrit has no effect on the direction of Supernus Pharmaceuticals i.e., Supernus Pharmaceuticals and Creative Edge go up and down completely randomly.

Pair Corralation between Supernus Pharmaceuticals and Creative Edge

Given the investment horizon of 90 days Supernus Pharmaceuticals is expected to generate 0.49 times more return on investment than Creative Edge. However, Supernus Pharmaceuticals is 2.04 times less risky than Creative Edge. It trades about 0.02 of its potential returns per unit of risk. Creative Edge Nutrit is currently generating about -0.04 per unit of risk. If you would invest  3,523  in Supernus Pharmaceuticals on August 30, 2024 and sell it today you would earn a total of  176.00  from holding Supernus Pharmaceuticals or generate 5.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Supernus Pharmaceuticals  vs.  Creative Edge Nutrit

 Performance 
       Timeline  
Supernus Pharmaceuticals 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Supernus Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent basic indicators, Supernus Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Creative Edge Nutrit 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Creative Edge Nutrit has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Creative Edge is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Supernus Pharmaceuticals and Creative Edge Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Supernus Pharmaceuticals and Creative Edge

The main advantage of trading using opposite Supernus Pharmaceuticals and Creative Edge positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Supernus Pharmaceuticals position performs unexpectedly, Creative Edge can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Creative Edge will offset losses from the drop in Creative Edge's long position.
The idea behind Supernus Pharmaceuticals and Creative Edge Nutrit pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges